Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-3-26
pubmed:abstractText
Following the discovery of RPR200765, a series of pyrimidine analogues have been prepared as backups. Amongst them, RPR203494 was identified with a better in vitro profile than RPR200765A.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
12
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
693-6
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11266171-Analysis of Variance, pubmed-meshheading:11266171-Animals, pubmed-meshheading:11266171-Area Under Curve, pubmed-meshheading:11266171-Arthritis, Rheumatoid, pubmed-meshheading:11266171-Cells, Cultured, pubmed-meshheading:11266171-Cytochrome P-450 Enzyme System, pubmed-meshheading:11266171-Dose-Response Relationship, Drug, pubmed-meshheading:11266171-Enzyme Inhibitors, pubmed-meshheading:11266171-Humans, pubmed-meshheading:11266171-Lipopolysaccharides, pubmed-meshheading:11266171-Male, pubmed-meshheading:11266171-Mice, pubmed-meshheading:11266171-Mitogen-Activated Protein Kinases, pubmed-meshheading:11266171-Molecular Structure, pubmed-meshheading:11266171-Monocytes, pubmed-meshheading:11266171-Pyrimidines, pubmed-meshheading:11266171-Random Allocation, pubmed-meshheading:11266171-Rats, pubmed-meshheading:11266171-Rats, Inbred Lew, pubmed-meshheading:11266171-Recombinant Proteins, pubmed-meshheading:11266171-Tumor Necrosis Factor-alpha, pubmed-meshheading:11266171-p38 Mitogen-Activated Protein Kinases
pubmed:year
2001
pubmed:articleTitle
RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potency.
pubmed:affiliation
Aventis Pharma, Dagenham Research Centre, Essex, UK.
pubmed:publicationType
Journal Article